Tag: Biopharmaceutica

Theravance to proceed with plan to split business

SOUTH SAN FRANCISCO, Calif. (AP) —June 17, 2013 Bloomberg Business Week Drug developer Theravance Inc. plans to split into two independent, publicly traded companies after a royalty agreement it had ironed out with Irish drugmaker Elan Corp. PLC fell through.…

VistaGen Therapeutics Inc.Advancements

VistaGen Therapeutics Presents CardioSafe 3D(TM) and LiverSafe 3D(TM) Developments at International Society of Stem Cell Research’s 11th Annual Meeting VistaGen Therapeutics Inc. VSTA | 6/17/2013 10:29:22 AM VistaGen Therapeutics Presents CardioSafe 3D(TM) and LiverSafe 3D(TM) Developments at International Society of…

City Council Agenda June 12, 2013 – Public Hearing

Public Hearing On Genentech Master Plan Changes South San Francisco, CA June 7, 2013   AGENDA CITY COUNCIL CITY OF SOUTH SAN FRANCISCOREGULAR MEETING MUNICIPAL SERVICES BUILDING COMMUNITY ROOMWEDNESDAY , JUNE 12, 2013 7:00 P.M. PEOPLE OF SOUTH SAN FRANCISCOYou…

Theravance to separate company into two benefits public trading

Theravance Announces Plan to Separate Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations Designed to Unlock Potential Value, Facilitate Return of Capital to Stockholders and Further Strategy of Advancing Medicines That Address Unmet Medical Needs SOUTH SAN FRANCISCO, CA — (Marketwired)…